Cargando…
Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
BACKGROUND/AIM: The aim of this study was to evaluate the effects of a 6-month treatment regimen with exenatide on the lipid profile, high-sensitivity C-reactive protein (hsCRP), carotid intima media thickness (CIMT), visceral adiposity, and nonalcoholic fatty liver disease (NAFLD), all of which are...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991851/ https://www.ncbi.nlm.nih.gov/pubmed/32892547 http://dx.doi.org/10.3906/sag-2004-154 |